FDA chastises three US firms for ignoring record requests, inadequate CMO oversight, and shoddy response to fires
Regulatory NewsJoanne S. Eglovitch
Audit/inspectionComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory NewsJoanne S. EglovitchAudit/inspectionComplianceNorth AmericaPharmaceuticalsQuality Assurance and Control